KLL, M., K, M., RS, M., S, B., L, J., MG, d. S., . . . F, P. (2024). Amelioration of Neurochemical Alteration and Memory and Depressive Behavior in Sepsis by Allopurinol, a Tryptophan 2,3-Dioxygenase Inhibitor. CNS & neurological disorders drug targets, 23(12), 1499. https://doi.org/10.2174/0118715273282363240415045927
Chicago Style (17th ed.) CitationKLL, Metzker, et al. "Amelioration of Neurochemical Alteration and Memory and Depressive Behavior in Sepsis by Allopurinol, a Tryptophan 2,3-Dioxygenase Inhibitor." CNS & Neurological Disorders Drug Targets 23, no. 12 (2024): 1499. https://doi.org/10.2174/0118715273282363240415045927.
MLA (9th ed.) CitationKLL, Metzker, et al. "Amelioration of Neurochemical Alteration and Memory and Depressive Behavior in Sepsis by Allopurinol, a Tryptophan 2,3-Dioxygenase Inhibitor." CNS & Neurological Disorders Drug Targets, vol. 23, no. 12, 2024, p. 1499, https://doi.org/10.2174/0118715273282363240415045927.